$AUTL News

Autolus Therapeutics plc 2026 Q2 - Results - Earnings Call Presentation

Autolus Therapeutics plc (AUTL) Q2 2026 Earnings Call Transcript

Autolus Therapeutics Affirms FY2026 Sales Guidance of $140.000M-$150.000M vs $136.669M Est

Autolus Therapeutics Q2 EPS $(0.15) Beats $(0.23) Estimate, Sales $45.689M Beat $34.016M Estimate

HC Wainwright & Co. Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target

Autolus Therapeutics Reports Preliminary Q2 AUCATZYL Sales Of ~$45M; Raises FY2026 Sales Guidance From $120M-$135M To $140M-$150M

Autolus Therapeutics: Navigating A Bumpy 2026

European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading

Autolus Therapeutics PLC (AUTL) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...

Autolus Therapeutics plc (AUTL) Q1 2026 Earnings Call Transcript

Autolus Therapeutics plc 2026 Q1 - Results - Earnings Call Presentation

Autolus Therapeutics Q1 Earnings Call Highlights

HC Wainwright & Co. Maintains Buy on Autolus Therapeutics, Raises Price Target to $10

Autolus Therapeutics (NASDAQ:AUTL) Posts Inline Q1 Results with First Positive Gross Margin, but Full-Year Guidance Slightly Below Consensus

Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

Autolus Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript

Autolus Therapeutics Sees FY2026 Sales $120.000M-$135.000M vs $130.062M Est

Autolus Therapeutics Q1 EPS $(0.27), Inline, Sales $26.218M Beat $26.160M Estimate

Autolus Therapeutics (AUTL) to Cut Workforce by 13% While Doubling 2026 Manufacturing Capacity

Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026